Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
AstraZeneca PLC 06 March 2025 6 March 2025 Transactions by Persons Discharging Managerial Responsibilities AstraZeneca PLC (the Company...
AstraZeneca PLC 05 March 2025 5 March 2025 Transactions by Persons Discharging Managerial Responsibilities AstraZeneca PLC (the Company...
AstraZeneca PLC 03 March 2025 3 March 2025 Transparency Directive Voting rights and capital The following notification is made in...
AstraZeneca PLC on Monday said its lung cancer drug Imfinzi has been recommended for approval in the EU. The Cambrid ...
AstraZeneca PLC 03 March 2025 3 March 2025 Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable...
An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was fi ...
AstraZeneca PLC on Friday said its breast cancer therapy, Enhertu, which is being developed jointly with Tokyo-based ...
AstraZeneca PLC 28 February 2025 28 February 2025 Enhertu recommended for approval in the EU by CHMP for patients with HER2-low or...
AstraZeneca PLC on Wednesday said its drug camizestrant significantly delayed disease progression in a phase III tria ...
AstraZeneca PLC 26 February 2025 This announcement contains inside information 26 February 2025 Camizestrant demonstrated highly...
AstraZeneca PLC 19 February 2025 19 February 2025 Filing of Annual Report on Form 20-F with the US Securities and Exchange Commission ...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지